Our findings from patient blood samples are the first ex vivo assay to support that both haploinsufficiency and truncation of STXBP1 protein (either dominant negative or haploinsufficiency) are causative mechanisms for epileptic encephalopathies, intellectual disability and developmental delay. This evidence concerns the gene STXBP1 and Epileptic encephalopathy.